Imatinib Tablets IP 400 mg are a targeted cancer treatment used primarily for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). These tablets work by blocking abnormal proteins that trigger cancer cell growth. Imatinib Tablets IP 400 mg are prescribed by oncologists for their proven effectiveness in managing and slowing disease progression. Patients benefit from improved outcomes when treated with Imatinib Tablets IP 400 mg under proper medical supervision. The medication is usually taken once daily and should be used exactly as prescribed. Oddway International supplies high-quality formulations globally, ensuring patients receive safe and authentic cancer medications. Always consult a healthcare provider for dosage and usage guidelines. Stay informed with trusted sources for reliable cancer treatment options and pharmaceutical updates.